KR102258231B1 - 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물 - Google Patents

미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물 Download PDF

Info

Publication number
KR102258231B1
KR102258231B1 KR1020190131354A KR20190131354A KR102258231B1 KR 102258231 B1 KR102258231 B1 KR 102258231B1 KR 1020190131354 A KR1020190131354 A KR 1020190131354A KR 20190131354 A KR20190131354 A KR 20190131354A KR 102258231 B1 KR102258231 B1 KR 102258231B1
Authority
KR
South Korea
Prior art keywords
virus
polypeptide
parsley
expression
seq
Prior art date
Application number
KR1020190131354A
Other languages
English (en)
Korean (ko)
Other versions
KR20210047574A (ko
Inventor
주성수
Original Assignee
강릉원주대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강릉원주대학교 산학협력단 filed Critical 강릉원주대학교 산학협력단
Priority to KR1020190131354A priority Critical patent/KR102258231B1/ko
Priority to PCT/KR2020/095011 priority patent/WO2021080400A1/fr
Priority to KR1020210030437A priority patent/KR102365266B1/ko
Publication of KR20210047574A publication Critical patent/KR20210047574A/ko
Application granted granted Critical
Publication of KR102258231B1 publication Critical patent/KR102258231B1/ko

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Epidemiology (AREA)
KR1020190131354A 2019-10-22 2019-10-22 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물 KR102258231B1 (ko)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020190131354A KR102258231B1 (ko) 2019-10-22 2019-10-22 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물
PCT/KR2020/095011 WO2021080400A1 (fr) 2019-10-22 2020-03-05 Polypeptide dérivé de l'oenanthe javanica et composition pharmaceutique le comprenant
KR1020210030437A KR102365266B1 (ko) 2019-10-22 2021-03-08 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190131354A KR102258231B1 (ko) 2019-10-22 2019-10-22 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020210030437A Division KR102365266B1 (ko) 2019-10-22 2021-03-08 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물

Publications (2)

Publication Number Publication Date
KR20210047574A KR20210047574A (ko) 2021-04-30
KR102258231B1 true KR102258231B1 (ko) 2021-05-31

Family

ID=75620631

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190131354A KR102258231B1 (ko) 2019-10-22 2019-10-22 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물

Country Status (2)

Country Link
KR (1) KR102258231B1 (fr)
WO (1) WO2021080400A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050281816A1 (en) 2002-10-11 2005-12-22 Norbert Lamping Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
KR100767701B1 (ko) 2004-04-24 2007-10-18 김상희 모노아세틸디아실글리세롤류 화합물을 유효성분으로 함유하는 면역조절제 및 항암제
KR20100038968A (ko) * 2008-10-07 2010-04-15 숙명여자대학교산학협력단 실크 펩타이드 및 사이토카인을 유효성분으로 함유하는 것을 특징으로 하는 면역 증강 또는 항암용 조성물
KR101617082B1 (ko) * 2014-04-10 2016-05-02 강릉원주대학교산학협력단 청각 유래 면역 증진용 약학적 조성물 및 이의 제조 방법
US20180117171A1 (en) * 2015-04-01 2018-05-03 President And Fellows Of Harvard College Immunoconjugates for programming or reprogramming of cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050281816A1 (en) 2002-10-11 2005-12-22 Norbert Lamping Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Evidence-Based Complementary and Alternative Medicine, 2019, Article ID 6495819, 17

Also Published As

Publication number Publication date
WO2021080400A1 (fr) 2021-04-29
KR20210047574A (ko) 2021-04-30

Similar Documents

Publication Publication Date Title
US11905536B2 (en) Anti-inflammatory peptides and composition comprising the same
KR102578891B1 (ko) 항염증 활성을 갖는 펩티드 및 이를 포함하는 조성물
JP6262722B2 (ja) 関節リウマチの予防用または治療用組成物
US8722616B2 (en) Anti-HIV peptides and methods of use thereof
KR102258231B1 (ko) 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물
EP2797617B1 (fr) Thérapie d'adjuvant anti-tumeur
KR102365266B1 (ko) 미나리 유래 폴리펩티드 및 상기 폴리펩티드를 포함하는 약학적 조성물
WO2015072750A1 (fr) Peptide à activité anti-inflammatoire et composition le comprenant
KR20240019135A (ko) 작제물과 면역자극 화합물의 공동발현
US20230203204A1 (en) Fusion protein, preparation method therefor and use thereof
KR101783030B1 (ko) C형 간염 바이러스 감염 또는 감염과 관련된 질병의 예방 또는 치료용 약학 조성물
US7157552B2 (en) Mutant trichosanthin
KR20210023737A (ko) 신규 인터페론 람다 변이체 및 이의 제조방법
TW202216747A (zh) 包含類升糖素胜肽—１及介白素—１受體拮抗物的融合蛋白及其用途
CN115955976A (zh) 工程化白介素-22多肽及其用途
KR20210021992A (ko) 망막 색소 변성증 치료용 펩티드
TWI634210B (zh) 抑制熱休克蛋白質表現之胜肽及包含其之組成物
US5459063A (en) Plasmodium falciparum ribonucleotide reductase DNA
KR102397510B1 (ko) 난소 기능 보존용 펩티드 및 이를 포함하는 조성물
CN116785402B (zh) 预防和/或治疗乳腺癌的多肽及其应用
EP4183803A1 (fr) Protéine de fusion comprenant un domaine extracellulaire de sous-unité alpha du récepteur fc d'ige et un anticorps anti-il-4r, et utilisation associée
CN118043066A (zh) 构建体和免疫刺激性化合物的共表达
CN113423731A (zh) 抗hiv抗体及其制造方法
WO2014171721A1 (fr) Facteur ik et utilisation pharmaceutique d'un acide nucléique codant pour le facteur ik
TW202417473A (zh) 抗發炎胜肽及包含其之成分

Legal Events

Date Code Title Description
A107 Divisional application of patent
E701 Decision to grant or registration of patent right
GRNT Written decision to grant